SecBot SecBot
8-K ·Filed Oct 6, 2026

NXPL

NextPlat Corp
BULLISH
Impact 5/10
Horizonweeks Processed21d 4h ago SEC0001437749-26-032200
8-K context-dependent: Items 8.01
Actionable Insight ▲ Bullish

The acquisition adds a profitable, debt-free pharmacy at a low revenue multiple (~0.27x sales) and expands NextPlat's footprint into an underserved Florida market. Watch for integration updates and Q4 2026 segment reporting to assess margin accretion from higher-margin contracted services.

DirectionBullish
Confidencehigh
Horizonweeks
Latest settled — T+5d ⚠ clustered
NXPL ▼ -1.88% at T+5d
LONG call ✗ call lost -1.88% · α vs SPY -0.90% · entry $9.29 → $9.12
Next anchor: T+20d in 6d
Latest observation: T+12 -4.83% FF3 residual α
Entry = T+0 close
Oct 6, 2026
via day close
T+1d
-1.51%
call -1.51% · α -1.08%
$9.15
settled 21d ago
T+5d
-1.88%
call -1.88% · α -0.90%
$9.12
settled 15d ago
T+20d
Pending
in 6d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

NextPlat Corp completed the acquisition of an independent pharmacy near Pensacola, Florida for $1,485,439 in cash. The acquired pharmacy generated approximately $5.6 million in sales for the year ended December 31, 2025, was profitable, and operated debt-free. The acquisition expands NextPlat's PharmcoRx healthcare segment into an underserved market and is expected to contribute to growth in Q4 2026.

Key Facts

  • Acquisition completed on October 6, 2026 for total cash consideration of $1,485,439
  • Acquired pharmacy generated approximately $5.6 million in sales for the year ended December 31, 2025
  • Pharmacy was profitable, maintained positive working capital, and operated with a debt-free balance sheet
  • Acquisition expands NextPlat's PharmcoRx network to five pharmacies in Florida
  • Company plans to introduce higher-margin contracted services (340B, long-term care, senior living) in the region

Financial Impact

Acquisition cost of $1,485,439; acquired pharmacy had ~$5.6M in trailing sales. The purchase price represents roughly 0.27x trailing sales, a low multiple for a profitable, debt-free pharmacy.

revenueprofitability

Risk Factors

  • Integration risk: successfully layering higher-margin services into the acquired pharmacy may take time
  • Small absolute size: the acquisition is modest relative to NextPlat's overall business, limiting near-term financial impact
  • Forward-looking statements about growth and profitability are aspirational and not guaranteed

Investment Themes

Media & Telecom

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001437749-26-032200
Exhibit: ex_1022839.htm0001437749-26-032200
Document: 0001437749-26-032200-index-headers.html0001437749-26-032200
Document: 0001437749-26-032200-index.html0001437749-26-032200
Document: 0001437749-26-032200.txt0001437749-26-032200
5 reports for NXPL
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for NXPL — sortable, filterable
TypeNow
Oct 13, 2026
14d ago
Press Release
NEUTRAL ★ 3/10
$9.00 $9.05▲ +0.50%▲ +1.65%$8.46 (−6.00%)
Oct 6, 2026
21d ago
8-K
BULLISH ★ 5/10
$9.29 $9.12▼ −1.88%▼ −0.90%$8.46 (−8.93%)
Oct 6, 2026
21d ago
Press Release
BULLISH ★ 5/10
$9.27 $9.00▼ −2.91%▼ −2.77%$8.46 (−8.74%)
Aug 13, 2026
10w ago
Press Release
MIXED ★ 6/10
$8.11 $8.57▲ +5.67%▲ +7.64%$8.46 (+4.32%)
Aug 3, 2026
12w ago
Press Release
NEUTRAL ★ 1/10
$6.10 $6.36▲ +4.26%▲ +2.23%$8.46 (+38.69%)
Showing 5 of 5

US Market Status

Market Closed — Opens Thu (12h 57m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 6, 2026